NONINFECTIOUS POSTERIOR UVEITIS BRINGING EMERGING TREATMENTS TO THE FOREFRONT

被引：0

作者：

Quan Dong Nguyen ^{[1
]}

Albini, Thomas ^{[2
]}

Callanan, David ^{[3
,4
]}

Goldberg, Jeffrey L. ^{[5
]}

Merrill, Pauline T. ^{[6
,7
]}

Landa, Gennady ^{[8
,9
,10
,11
]}

机构：

[1] Stanford Univ, Sch Med, Byers Eye Inst, Ophthalmol, Palo Alto, CA 94304 USA

[2] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Clin Ophthalmol, Miami, FL 33136 USA

[3] Texas Retina Associates, Arlington, TX USA

[4] Univ Texas Arlington, Southwestern Med Ctr, Dept Ophthalmol, Arlington, TX 76019 USA

[5] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA

[6] Rush Univ, Med Ctr, Dept Ophthalmol, Chicago, IL 60612 USA

[7] Illinois Retina Associates, Chicago, IL USA

[8] New York Eye & Ear Infirmatry Mt Sinai, Icahn Sch Med Mt Sinai, Ophthalmol, New York, NY 10029 USA

[9] New York Eye & Ear Infirmatry Mt Sinai, Retina Serv, New York, NY USA

[10] New York Eye & Ear Infirmatry Mt Sinai, Vitreoretinal Fellowship, Cleveland, OH USA

[11] New York Eye & Ear Infirmatry Mt Sinai, Dept Ophthalmol, New York, NY USA

来源：

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2020年 / 40卷

关键词：

FLUOCINOLONE ACETONIDE IMPLANT; SYSTEMIC ANTIINFLAMMATORY THERAPY; FOLLOW-UP; MULTICENTER; INTERMEDIATE; ADALIMUMAB; RECOMMENDATIONS; METHOTREXATE; PANUVEITIS; RETISERT;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页数：9